• Profile
Close

Serum IL27 in relation to risk of hepatocellular carcinoma in two nested case- control studies

Cancer Epidemiology, Biomarkers & Prevention Dec 16, 2020

Yuan JM, Wang Y, Wang R, et al. - Researchers sought to determine the link between serum IL27 concentrations and risk of developing hepatocellular carcinoma, by conducting two parallel case–control studies (each with 100 case–control pairs) in the Singapore Chinese Health Study and the Shanghai Cohort Study. For hepatocellular carcinoma, the odds ratios (OR) for the highest vs the lowest tertile of IL27 was estimated to be 46.08 [95% confidence interval (CI), 4.68–453.86] and 19.09 (95% CI, 3.81–95.57) in the Singapore Chinese Health Study and in the Shanghai Cohort Study, respectively. In both cohort studies, the corresponding ORs were estimated to be 42.47 (95% CI, 8.30–217.40) and 242.46 (95% CI, 38.42–1,529.01) in people negative for hepatitis B surface antigen (HBsAg) and in those positive for HBsAg, respectively, vs the lowest tertile of interleukin-27 and negative HBsAg. Overall, findings demonstrated that IL27 concentrations in prediagnostic sera were significantly related to elevated risk of hepatocellular carcinoma development.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay